Back to Results
First PageMeta Content
Gastroenterology / Exenatide / Sitagliptin / Glucagon-like peptide-1 / Glimepiride / Dipeptidyl peptidase-4 inhibitor / Glucose tolerance test / Anti-diabetic drugs / Endocrine system / Chemistry


SUPPLEMENTARY DATA Exenatide: The Investigator’s brochure from Eli Lilly and Company (http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021773s9s11s18s22s25lbl.pdf) indicates that the ‘mean apparent clearance
Add to Reading List

Document Date: 2014-06-20 11:12:30


Open Document

File Size: 649,96 KB

Share Result on Facebook
UPDATE